Cargando…

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease

OBJECTIVE: The nigral lesion and the resulting contralateral motor signs of Parkinson's disease (PD) are remarkably asymmetric. This study investigated the prevalence of patients with “wrong‐sided” lesions, that is, patients with symptoms on the side ipsilateral to the predominant dopaminergic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kaasinen, Valtteri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704477/ https://www.ncbi.nlm.nih.gov/pubmed/26783547 http://dx.doi.org/10.1002/acn3.268

Ejemplares similares

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2016)

Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?
por: Railo, Henry, et al.
Publicado: (2018)

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population
por: Kiyohara, Chikako, et al.
Publicado: (2011)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders
por: Wallert, Elon D., et al.
Publicado: (2022)

Parallel Appearance of Compulsive Behaviors and Artistic Creativity in Parkinson's Disease
por: Joutsa, Juho, et al.
Publicado: (2012)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission
por: Vajdi-Hokmabad, Reza, et al.
Publicado: (2017)

Dysfunctional dopaminergic neurotransmission in asocial BTBR mice
por: Squillace, M, et al.
Publicado: (2014)

Height and nigral neuron density in Parkinson’s disease
por: Saari, Laura, et al.
Publicado: (2022)

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016)

Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation
por: Martikainen, Mika H., et al.
Publicado: (2015)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Akinetic Crisis in Parkinson's Disease Is Associated with a Severe Loss of Striatal Dopamine Transporter Function: A Report of Two Cases
por: Kaasinen, Valtteri, et al.
Publicado: (2014)

Indirect evidence for altered dopaminergic neurotransmission in very premature‐born adults
por: Schinz, David, et al.
Publicado: (2023)

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies
por: Martini, Alice, et al.
Publicado: (2018)

Serotonergic and dopaminergic control of impulsivity in gambling disorder
por: Kaasinen, Valtteri, et al.
Publicado: (2023)

Deep brain stimulation for monogenic Parkinson’s disease: a systematic review
por: Kuusimäki, Tomi, et al.
Publicado: (2019)

Increased dopaminergic neurotransmission results in ethanol dependent sedative behaviors in Caenorhabditis elegans
por: Pandey, Pratima, et al.
Publicado: (2021)

Alteration of Striatal Dopaminergic Neurotransmission in a Mouse Model of DYT11 Myoclonus-Dystonia
por: Zhang, Lin, et al.
Publicado: (2012)

A Neural Population Model Incorporating Dopaminergic Neurotransmission during Complex Voluntary Behaviors
por: Fürtinger, Stefan, et al.
Publicado: (2014)

The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Floating door sign does not differentiate Parkinson’s disease from essential tremor
por: Räty, Valtteri, et al.
Publicado: (2023)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Modulation of dopaminergic neurotransmission in rat striatum upon in vitro and in vivo diclofenac treatment1
por: Milusheva, Elisaveta, et al.
Publicado: (2008)

Dopaminergic function and intertemporal choice
por: Joutsa, J, et al.
Publicado: (2015)

Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses
por: Aguilar-Valles, Argel, et al.
Publicado: (2020)

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
por: Concha‐Marambio, Luis, et al.
Publicado: (2021)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Towards a Reconceptualization of Striatal Interactions Between Glutamatergic and Dopaminergic Neurotransmission and Their Contribution to the Production of Movements
por: David, Hélène N
Publicado: (2009)

Binge-Like Alcohol Exposure During Adolescence Disrupts Dopaminergic Neurotransmission in the Adult Prelimbic Cortex
por: Trantham-Davidson, Heather, et al.
Publicado: (2017)

A role for neurotransmission and neurodevelopment in attention-deficit/hyperactivity disorder
por: Roman, Tatiana, et al.
Publicado: (2009)

Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
por: Flinkman, Dani, et al.
Publicado: (2023)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Psychoactive Drugs—From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review
por: Jîtcă, George, et al.
Publicado: (2021)

D1 Receptor Mediated Dopaminergic Neurotransmission Facilitates Remote Memory of Contextual Fear Conditioning
por: Saito, Nae, et al.
Publicado: (2022)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
por: Lebedev, Alexander V., et al.
Publicado: (2014)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit
por: Yu, Zhenwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d0660i8dnh9t8bm476j170gacg